Page 20 - 2022 DMOH Year-End Review Summary

Research Awards &

Achievements

Congratulations to Dr. Warren Mason for receiving the Canadian Cancer Trials Group
(CCTG) Dr. Joseph Pater Founder’s Award for his excellence in clinical trials research,
leadership, and his body of work that has contributed to significant advances in the
understanding, diagnosis, treatment, cure, and prevention of cancer. Read the full
story on the CCTG website.

Congratulations to Dr. Frances Shepherd for being awarded the Grand Prix Interna-
tional Scientifique (International Scientific Grand Prize) Award at the recent Interna-
tional and French Oncology Days (IFODS) Cancer Congress in Paris, France in June
2022.

Congratulations to Dr. Jean Wang for receiving the UHN Local Impact Award for
Commercialization & Discovery. This award recognizes their discoveries of cancer cell
interactions that led to the development of an immune therapy currently in clinical
trials for hematologic malignancies and solid tumours as well as a US $2.22 billion
pharmaceutical industry deal between Pfizer Inc. and Trillium Therapeutics. Read the
full story at UHN Newsroom.

Congratulations to Dr. Kevin Kuo, who was among a select
group of reviewers that were identified through CIHR’s Review
Quality Assurance (RQA) Process as an Outstanding Reviewer
in recognition of his exemplary contribution to peer review
for the Fall 2021 CIHR Project Grant competition. Among the
1,094 reviewers that participated in the competition, only 22.9%
obtained this recognition.

20  Division of Medical Oncology & Hematology